Majid Kazemi, Ali Motamed Nezhad, Razieh Hajisoltan, Fatemeh Ramezani, Soroush Taherkhani, Fariborz Moayer, Faraz Moayer, Atousa Janzadeh, Ali Dadseresht, Reza Ahadi, Negin Mojarad, Mina Eftekharzadeh, Fazel Gorjipour
{"title":"Photobiomodulation therapy: Location-dependent effects on memory and recovery in male adult rats with spinal cord injury.","authors":"Majid Kazemi, Ali Motamed Nezhad, Razieh Hajisoltan, Fatemeh Ramezani, Soroush Taherkhani, Fariborz Moayer, Faraz Moayer, Atousa Janzadeh, Ali Dadseresht, Reza Ahadi, Negin Mojarad, Mina Eftekharzadeh, Fazel Gorjipour","doi":"10.1093/jnen/nlaf051","DOIUrl":null,"url":null,"abstract":"<p><p>Spinal cord injuries (SCIs) can cause significant physical and emotional challenges for individuals as a result of inflammation and cell death. This study investigates the effectiveness of photobiomodulation therapy (PBMT) in reducing inflammation and memory impairment through the use of 3 specific treatment protocols. Forty male rats (180-200 g) were divided into 5 groups: Control; SCI model; and SCI with 3 different PBMT protocols. The rats underwent behavioral tests (Novel Object Recognition and Shuttle Box), histological examination (H&E and Nissl staining), and protein analysis (HDAC2, NF-kB [p65], IkB-α, and BDNF) using Western blot of medial prefrontal cortex (mPFC) and hippocampal tissues. PBMT effectively decreased NF-κB levels in the mFPC in all 3 PBMT protocols. The third PBMT3 protocol with the highest energy delivery, which included both the spinal cord and skull had the greatest impact on regulating the expression of this inflammatory factor. Behavioral assessments revealed that the PBMT3 protocol led to the most significant enhancement in cognition. The therapeutic effects of PBMT on memory are thought to be mediated by the enhancement of neurotrophic factors such as BDNF and the reduction of inflammatory mediators, which can impair hippocampal and mPFC function.</p>","PeriodicalId":16682,"journal":{"name":"Journal of Neuropathology and Experimental Neurology","volume":" ","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neuropathology and Experimental Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/jnen/nlaf051","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Spinal cord injuries (SCIs) can cause significant physical and emotional challenges for individuals as a result of inflammation and cell death. This study investigates the effectiveness of photobiomodulation therapy (PBMT) in reducing inflammation and memory impairment through the use of 3 specific treatment protocols. Forty male rats (180-200 g) were divided into 5 groups: Control; SCI model; and SCI with 3 different PBMT protocols. The rats underwent behavioral tests (Novel Object Recognition and Shuttle Box), histological examination (H&E and Nissl staining), and protein analysis (HDAC2, NF-kB [p65], IkB-α, and BDNF) using Western blot of medial prefrontal cortex (mPFC) and hippocampal tissues. PBMT effectively decreased NF-κB levels in the mFPC in all 3 PBMT protocols. The third PBMT3 protocol with the highest energy delivery, which included both the spinal cord and skull had the greatest impact on regulating the expression of this inflammatory factor. Behavioral assessments revealed that the PBMT3 protocol led to the most significant enhancement in cognition. The therapeutic effects of PBMT on memory are thought to be mediated by the enhancement of neurotrophic factors such as BDNF and the reduction of inflammatory mediators, which can impair hippocampal and mPFC function.
期刊介绍:
Journal of Neuropathology & Experimental Neurology is the official journal of the American Association of Neuropathologists, Inc. (AANP). The journal publishes peer-reviewed studies on neuropathology and experimental neuroscience, book reviews, letters, and Association news, covering a broad spectrum of fields in basic neuroscience with an emphasis on human neurological diseases. It is written by and for neuropathologists, neurologists, neurosurgeons, pathologists, psychiatrists, and basic neuroscientists from around the world. Publication has been continuous since 1942.